Stephan Andreas Brackmann

Stephan Andreas Brackmann is an Associate Professor at the University of Oslo, affiliated with the Division of Medicine and Laboratory Sciences. His research focuses on inflammatory bowel disease (IBD), colorectal cancer, and microbiota dynamics. He leads projects investigating microbial patterns in IBD, molecular biomarkers for cancer detection, and long-term outcomes in gastrointestinal disorders.

Key contributions include studies on fecal microbiota composition in untreated IBD patients, DNA methylation-based diagnostics for colorectal neoplasia, and population-based cohort analyses like the IBSEN study. His work spans gastroenterology, oncology, and immunology, emphasizing translational research for clinical applications.

Recent publications (2023-2025) highlight advancements in mucosal gene transcript analysis, microbial signatures in CRC progression, and temporal trends in IBD management. Brackmann collaborates extensively with European and Norwegian medical institutions, contributing to improved diagnostic tools and surveillance protocols.